Effect of vitamins on the lipid profile of patients on regular hemodialysis

Scandinavian Journal of Urology and Nephrology

Volumn 34, Issue 1, 2000, Pages 62-66

  Khajehdehi, Parviz ^a  

^a NONE   (Iran)

Author keywords

Chronic renal failure; Hemodialysis; Hyperlipidemia; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; COLECALCIFEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL; VITAMIN;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 0034046635     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655900750016913     Document Type: Article

References (25)

1. 1. Loughrey CM, Young IS, Lightbody JH, McMaster D, McNamee PT, Trimble ER. Oxidative stress in hemodialysis. Q J Med 1994; 87: 679-83.
2. 2. Maggie E, Bellazzi R, Falaschi F, Frattoni A, Perani G, Finardi G, et al. Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis? Kidney Int 1994; 45: 876-83.
3. 3. Jacob RA, Burri BJ. Oxidative damage and defense. Am J Clin Nutr 1996; 63: 985S-990S.
4. 4. Malinow MR. Adverse effects of the treatment for hyperlipidemia. Cardiol Clin 1986; 4: 95-103.
5. 5. Newman TB, Hulley SB. Carcinogenicity of lipid-lowering drugs. JAMA 1996; 275: 55-60.
6. 6. Williams GM, Perrone C. Mechanism-based risk assessment of peroxisome proliferating rodent hepatocarcinogens. Ann NY Acad Sci 1996; 804: 554-72.
7. 7. Sum CF, Tan CE, Chew LS. Management of hyperlipidemia. Singapore Med J 1995; 36: 410-16.
8. 8. Westhuvzen J, Adams CE, Fleming SJ. Evidence for oxidative stress during in vitro dialysis. Nephron 1995; 70: 49-54.
9. 9. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 1995; 41: 1135-8.
10. 10. Jha P, Flather M, Lonn E, Farkouh H, Yusuf S. The antioxidant vitamins and cardiovascular diseases. A critical review of epidemiologic and clinical trial data. Ann Intern Med 1995; 123: 860-72.
11. 11. Peuchant E, Carbonneau MA, Dubourg L, Thomas MJ, Perromat A, Vallot C, Clerc M. Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: vitamin A, E, and iron status. Free Radic Biol Med 1994; 16: 339-46.
12. 12. Jendrvczko A, Grzesxczak W, Gorczvca E. Lipid peroxides and vitamin E in plasma and plasma lipoproteins in blood of patients with chronic hemodialysis. Pol Arch Med Wewn 1994; 92: 123-8.
13. 13. Yeksan M, Turk S, Polat M, Cigli A, Erdogan Y. Effects of 1.25 (OH)2D3 treatment on lipid levels in uremic hemodialysis patients. Int J Artif Organs 1992; 15: 704-7.
14. 14. Lind L, Lithel H, Wengle B, Werge U, Ljunghall S. A pilot study of metabolic effects of intravenously given alpha-calcidol in patients with chronic renal failure. Scand J Urol Nephrol 1988; 22: 219-22.
15. 15. Coffery MD, Cole RA, Colles SM, Chisoim GM. In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals. J Clin Invest 1995; 96: 1866-73.
16. 16. Swain R, Kaplan B. Vitamins as therapy in the 1990s. J Am Board Fam Prac 1995; 8: 206-16.
17. 17. Galle J, Wanner C. Oxidative stress and vascular injury relevant for atherogenesis in uremic patients? Nephrol Dial Transplant 1997; 12: 2480-3.
18. 18. Gilmour ER, Hartley GH, Goodship THJ. Trace elements and vitamins in renal disease. In: Mitch WE, Klahr S, editors. Nutrition and the kidney. Boston: Little Brown, 1993: 114-31.
19. 19. Kritchevsky SB, Shimakawa T, Tell GS, Dennis R, Carpenter M, Fckfeldt JH, et al. Dietary antioxidant and carotid wall thickness, The ARIC Study. Circulation 1995; 92: 2142-50.
20. 20. Hodis HN, Mack WJ, LaBaree L, Cashin-Hemphill L, Sevanian A, Johnson R, Azen SP. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 1995; 273: 1849-54.
21. 21. Mancini M, Parfitt VJ, Rubba P. Antioxidant in the Mediterranean diet. Can J Cardiol 1995; 11 (Suppl G): 105G-9G.
22. 22. Maclin LJ. Critical assessment of the epidemiological data concerning the impact of the antioxidant nutrients on cancer and cardiovascular disease. Crit Rev Food Sci Nutr 1995; 35: 41-50.
23. 23. Boeshoten EW, Schriever J, Krediet RT, Arisz L. Vitamin deficiencies in CAPD patients. Perit Dial Bull 1984; 4 (Suppl): S7.
24. 24. Nishizawa Y, Shoji T, Kawagishi T, Morri H. Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation. Kidney Int 1997; 52 (Suppl 62): S90-S2.
25. 25. Cohen JJ, Harrington JT, Cassirer JP, Madias NE. Lipid abnormalities in renal disease. Kidney Int 1991; 39: 169-83.